Clinical Trial Update: Safety and Effects of Implanted (Autologous) Skeletal Myoblasts (MyoCell) Using an Injection Catheter = SEISMIC Trial [Phase 2]

View source ↗

Summary

Phase 2 trial update examining the safety and effects of implanted autologous skeletal myoblasts (MyoCell) delivered via an injection catheter. The study target…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Myocardial Infarction

Drugs mentioned

• MyoCell (autologous skeletal myoblasts)

Snippet

Sponsor: Bioheart, Inc. | Conditions: Myocardial Infarction, Heart Failure, Congestive | Phase 2 | Status: UNKNOWN